Old Web
English
Sign In
Acemap
>
authorDetail
>
Peter Pieslor
Peter Pieslor
Amgen
Medicine
Antibody
Pharmacology
Monoclonal antibody
Toxicity
3
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors
2014
Investigational New Drugs
Margaret von Mehren
Carolyn D. Britten
Peter Pieslor
Wayne Saville
Artemios Vassos
Sarah Harris
Gerald R. Galluppi
Mohamed Darif
Zev A. Wainberg
Roger B. Cohen
Stephen Leong
Show All
Source
Cite
Save
Citations (10)
AMG 900, a Potent and Highly Selective Aurora Kinase Inhibitor Shows Promising Preclinical Activity Against Acute Myeloid Leukemia Cell Lines In Vitro and In Vivo
2013
Blood
Kam Cheung
Gloria Juan
William Wayne
Kelly Hanestad
Kathleen Keegan
Justin Huard
Patricia McElroy
Mary K. Stanton
Tammy L. Bush
Richard Kendall
Robert Radinsky
Steve Abella
Peter Pieslor
Gregory Friberg
Angela Coxon
Erick Gamelin
Show All
Source
Cite
Save
Citations (3)
Phase I, dose-escalation study of BIIB022 (anti-IGF-1R antibody) in advanced solid tumors.
2010
Journal of Clinical Oncology
M. von Mehren
Carolyn D. Britten
K. Lear
D. R. Camidge
Zev A. Wainberg
Peter Pieslor
Mohamed Darif
Sarah Harris
K. Balogh
Stephen Leong
Show All
Source
Cite
Save
Citations (13)
1